Form 8-K - Current report:
SEC Accession No. 0001410939-20-000028
Filing Date
2020-06-15
Accepted
2020-06-15 06:19:44
Documents
20
Period of Report
2020-06-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kx2020clinicaltrial.htm   iXBRL 8-K 193486
2 EXHIBIT 99.1 zimuraoph200318monthpr.htm EX-99.1 44054
8 zimuraoph200318monthp_image1.jpg GRAPHIC 18564
9 zimuraoph200318monthp_image2.gif GRAPHIC 18989
10 zimuraoph200318monthp_image3.gif GRAPHIC 18101
11 zimuraoph200318monthp_image4.gif GRAPHIC 16219
12 zimuraoph200318monthp_image5.gif GRAPHIC 16341
  Complete submission text file 0001410939-20-000028.txt   526657

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opht-20200615.xsd EX-101.SCH 4454
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opht-20200615_cal.xml EX-101.CAL 627
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opht-20200615_def.xml EX-101.DEF 1477
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opht-20200615_lab.xml EX-101.LAB 27268
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opht-20200615_pre.xml EX-101.PRE 14117
14 EXTRACTED XBRL INSTANCE DOCUMENT a8-kx2020clinicaltrial_htm.xml XML 4883
Mailing Address ONE PENN PLAZA 35TH FLOOR NEW YORK NY 10119
Business Address ONE PENN PLAZA 35TH FLOOR NEW YORK NY 10119 212-845-8200
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

EIN.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36080 | Film No.: 20961859
SIC: 2834 Pharmaceutical Preparations